BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/14/2026 7:54:24 AM | Browse: 8 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 117832
Country Germany
Category Oncology
Manuscript Type Observational Study
Article Title Five-fraction stereotactic magnetic resonance-guided adaptive radiotherapy targeting the primary tumor in metastatic pancreatic cancer
Manuscript Source Unsolicited Manuscript
All Author List Mohamed A Schumann, Aurélie Gaasch, Sandra Boyaci, Frederik Fuchs, Franziska Walter, Sebastian N Marschner, Chukwuka Eze, Christoph Benedikt Westphalen, Julian Walter Holch, Georg Beyer, Wolfgang G Kunz, Julia Mayerle, Maximilian Niyazi, Claus Belka, Stefanie Corradini and Paul Rogowski
Funding Agency and Grant Number
Corresponding Author Mohamed A Schumann, Department of Radiation Oncology, LMU University Hospital, Marchioninistrasse 15, Munich 81377, Germany. mohamed.schumann@med.uni-muenchen.de
Key Words Pancreatic cancer; Pancreatic ductal adenocarcinoma; Radiotherapy; Stereotactic body radiotherapy; Metastatic pancreatic ductal adenocarcinoma; Magnetic resonance-guided radiotherapy
Core Tip Local progression of the primary tumor remains a major cause of morbidity in metastatic pancreatic ductal adenocarcinoma, even in the era of modern chemotherapy. This prospective observational study demonstrates that five-fraction stereotactic magnetic resonance-guided radiotherapy to the primary tumor is feasible and safe in patients with metastatic pancreatic ductal adenocarcinoma, achieving good local control, meaningful pain palliation, and low rates of high-grade toxicity. These findings support magnetic resonance-guided radiotherapy as a promising local treatment option within multimodal strategies for carefully selected patients with controlled metastatic disease.
Citation Schumann MA, Gaasch A, Boyaci S, Fuchs F, Walter F, Marschner SN, Eze C, Westphalen CB, Holch JW, Beyer G, Kunz WG, Mayerle J, Niyazi M, Belka C, Corradini S, Rogowski P. Five-fraction stereotactic magnetic resonance-guided adaptive radiotherapy targeting the primary tumor in metastatic pancreatic cancer. World J Gastroenterol 2026; In press
Received
2025-12-18 11:55
Peer-Review Started
2025-12-18 11:55
First Decision by Editorial Office Director
2026-01-15 07:39
Return for Revision
2026-01-15 07:39
Revised
2026-01-27 15:52
Publication Fee Transferred
2026-03-05 12:45
Second Decision by Editor
2026-04-14 02:38
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-04-14 07:54
Articles in Press
2026-04-14 07:54
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com